PharmaShots | Incisive News in 3 Shots

Subscribe Now

Spectrum

Spectrum Presents Results of Poziotinib in (ZENITH20) Clinical Trial as 1L Treatment of NSCLC at ESMO TAT 2022

Spectrum Presents Results of Poziotinib in (ZENITH20) Clinical Trial as 1L Treatment of NSCLC at ESMO TAT 2022

March 7, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us